1. The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment 
Stefan Baral, MD, Amrita Rao, ScM, Patrick Sullivan, PhD, Nancy Phaswana-Mafuya, PhD, Daouda Diouf, MS, Greg Millett, MPH, Helgar Musyoki, MPH, Elvin Geng, MD, Sharmistha Mishra, PhD 
The Lancet HIV 
DOI: /S (19)
Copyright © 2019 Elsevier Ltd Terms and Conditions

2. Figure 1
Experimental studies evaluating HIV treatment outcomes at the population level and individual level
Details of studies and comparisons are given in the main text. Blue lines represent studies with population-level outcomes and red lines are studies with individual-level outcomes. aHR=adjusted hazard ratio. aRR=risk ratio. IRR=incidence rate ratio. ART=antiretroviral therapy.
The Lancet HIV DOI: ( /S (19) )
Copyright © 2019 Elsevier Ltd Terms and Conditions

3. Figure 2
Numbers of new HIV infections and HIV treatment coverage in Botswana, Rwanda, and Ethiopia 2010–17
ART=antiretroviral therapy.
The Lancet HIV DOI: ( /S (19) )
Copyright © 2019 Elsevier Ltd Terms and Conditions